Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Warrior Met Coal
HCC
$5.64B
| $28.1M | 0.04% |
923,431
-1,117,690
| -55% | -$30.6M |
|
|
HOLX
602
CALL
DELISTED
Hologic
HOLX
| $28.1M | 0.04% |
580,000
+280,000
| +93% | +$12.6M |
|
603
Brinker International
EAT
$10.6B
| $27.8M | 0.04% |
627,433
+492,167
| +364% | +$22.2M |
|
604
PUT
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$137M
| $27.8M | 0.04% |
+14,844
| New | +$32.7M |
|
605
DNOW Inc
DNOW
$2.83B
| $27.8M | 0.04% |
1,990,571
-117,150
| -6% | -$1.63M |
|
|
BOLD
606
DELISTED
Audentes Therapeutics, Inc
BOLD
| $27.7M | 0.04% |
710,809
+119,835
| +20% | +$3.44M |
|
607
Mid-America Apartment Communities
MAA
$15.2B
| $27.6M | 0.04% |
252,498
+59,478
| +31% | +$6.12M |
|
608
AptarGroup
ATR
$8.57B
| $27.5M | 0.04% |
258,895
+93,701
| +57% | +$9.36M |
|
609
Molina Healthcare
MOH
$10.5B
| $27.5M | 0.04% |
193,649
-6,859
| -3% | -$928K |
|
|
EVBG
610
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $27.4M | 0.04% |
365,766
+217,858
| +147% | +$14.2M |
|
611
MacroGenics
MGNX
$261M
| $27.4M | 0.04% |
1,522,140
+1,264,460
| +491% | +$21.9M |
|
612
Cheesecake Factory
CAKE
$5.64B
| $27.3M | 0.04% |
558,301
+307,880
| +123% | +$14.2M |
|
613
Terreno Realty
TRNO
$7.43B
| $27.3M | 0.04% |
648,913
+528,755
| +440% | +$21.1M |
|
|
SKX
614
DELISTED
Skechers
SKX
| $27.3M | 0.04% |
811,209
-414,661
| -34% | -$12.4M |
|
615
Hershey
HSY
$37.5B
| $27.3M | 0.04% |
237,319
-222,995
| -48% | -$24.3M |
|
616
First American
FAF
$7.33B
| $27.2M | 0.04% |
528,798
-595,387
| -53% | -$29.5M |
|
617
BJ's Restaurants
BJRI
$1.42B
| $27.2M | 0.04% |
574,940
+125,280
| +28% | +$6.29M |
|
618
Highwoods Properties
HIW
$3.46B
| $27.2M | 0.04% |
580,600
-437,282
| -43% | -$19.5M |
|
619
Commault Systems
CVLT
$5.55B
| $27.1M | 0.04% |
419,092
+315,417
| +304% | +$20.4M |
|
620
MGM Resorts International
MGM
$11B
| $27.1M | 0.04% |
1,057,149
-393,689
| -27% | -$10.8M |
|
621
Fox Class A
FOXA
$28.8B
| $27.1M | 0.04% |
+738,282
| New | +$28.8M |
|
622
VanEck Gold Miners ETF
GDX
$32B
| $27.1M | 0.04% |
1,207,606
+953,859
| +376% | +$21M |
|
623
Bausch Health
BHC
$2.41B
| $27M | 0.04% |
1,094,027
-175,322
| -14% | -$4.19M |
|
624
Sarepta Therapeutics
SRPT
$1.98B
| $26.9M | 0.04% |
225,754
+74,349
| +49% | +$9.56M |
|
|
IPG
625
DELISTED
Interpublic Group of Companies
IPG
| $26.9M | 0.04% |
1,279,383
-2,090,100
| -62% | -$46.5M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.